Susan Morrison - 30 May 2025 Form 4 Insider Report for TANDEM DIABETES CARE INC (TNDM)

Role
EVP & Chief Admin. Officer
Signature
/s/ Rachel Malina, Attorney-in-Fact for Susan M. Morrison
Issuer symbol
TNDM
Transactions as of
30 May 2025
Net transactions value
$0
Form type
4
Filing time
05 Jun 2025, 17:25:47 UTC
Previous filing
19 May 2025
Next filing
19 Aug 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Morrison Susan EVP & Chief Admin. Officer 12400 HIGH BLUFF DRIVE, SAN DIEGO /s/ Rachel Malina, Attorney-in-Fact for Susan M. Morrison 05 Jun 2025 0001582970

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding TNDM Common Stock 37,206 30 May 2025 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TNDM Performance Stock Unit Award $0 +20,768 $0.000000 20,768 30 May 2025 Common Stock 20,768 Direct F1, F2
transaction TNDM Restricted Stock Unit Award $0 +20,768 $0.000000 20,768 30 May 2025 Common Stock 20,768 Direct F1, F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Awarded on May 30, 2025 pursuant to the Tandem Diabetes Care, Inc. 2023 Long-Term Incentive Plan, as amended, and agreements related thereto (the 2023 Plan).
F2 Each performance stock unit (PSU) represents a contingent right to receive one share of Tandem Diabetes Care, Inc. (the Company) common stock based upon the achievement of certain pre-defined performance metrics as of December 31, 2027 (the Measurement Date). The number of shares issued may range from 0% to 200% of the amount specified above, based upon (i) Company's actual performance relative to the pre-defined performance metrics, and (ii) subject to the awardee's continuing service through the Measurement Date. If minimum performance metrics are not met, no PSUs will vest.
F3 Each restricted stock unit (RSU) represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2023 Plan.
F4 RSU vest as to thirty-three percent (33%) of the total number of shares subject to the RSU on 5/15/2026, and the remaining shares shall vest in eight (8) equal quarterly installments thereafter.